Call for Papers  

Article Details


Therapeutic Management with Repurposing Approaches: A Mystery During COVID-19 Outbreak

[ Vol. 24 , Issue. 6 ]

Author(s):

Soumik Chaudhury, Paranjeet Kaur*, Deepali Gupta, Palak Anand, Manish Chaudhary, Siddhita Tiwari, Amit Mittal, Jeena Gupta, Sukhmeen Kaur, Varsh Deep Singh, Dakshita Dhawan, Princejyot Singh and Sanjeev Kumar Sahu*   Pages 712 - 733 ( 22 )

Abstract:


The ubiquitous pandemic that emerged due to COVID-19 affected the whole planet. People all over the globe became vulnerable to the unpredictable emergence of coronavirus. The sudden emergence of respiratory disease in coronavirus infected several patients. This affected human life drastically, from mild symptoms to severe illness, leading to mortality. COVID-19 is an exceptionally communicable disease caused by SARS-CoV-2. According to a genomic study, the viral spike RBD interactions with the host ACE2 protein from several coronavirus strains and the interaction between RBD and ACE2 highlighted the potential change in affinity from the virus causing the COVID-19 outbreak to a progenitor type of SARS-CoV-2. SARS-CoV-2, which could be the principal reservoir, is phylogenetically related to the SARS-like bat virus. Other research works reported that intermediary hosts for the transmission of viruses to humans could include cats, bats, snakes, pigs, ferrets, orangutans, and monkeys. Even with the arrival of vaccines and individuals getting vaccinated and treated with FDAapproved repurposed drugs like Remdesivir, the first and foremost steps aimed towards the possible control and minimization of community transmission of the virus include social distancing, self-realization, and self-health care. In this review paper, we discussed and summarized various approaches and methodologies adopted and proposed by researchers all over the globe to help with the management of this zoonotic outbreak by following repurposed approaches.

Keywords:

COVID-19, pandemic, repurposing, infection, treatment, promising facilitator.

Affiliation:



Read Full-Text article